Application of Growth Hormone in Patients with Non-ovarian Hyporesponsiveness and Poor Embryonic Development

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-16010209

Enrollment

Unknown

Registered

2016-12-21

Start date

2017-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility Disease

Interventions

study group:Growth hormone

control group:No

Eligibility

Sex/Gender

Female

Age

30 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) Aged 30 to 40 years old; (2) Previous IVF/ICSI cycles + long-regimen/antagonist regimen, poor embryonic development (excellent embryo rate=20%) or no transplantable embryos; (3) Had never received growth hormone therapy and no growth hormone contraindications.

Exclusion criteria

Exclusion criteria: (1) Previous ovarian hyporesponsive patients; (2) No embryos available due to failure of previous fertilization; (3) Ovum donation, PGD and PGS; (4) Ovum abnormalities; (5) One or both spouses have chromosomal abnormalities; (6) Patients with the following abnormal uterus: uterine malformations (unicornous uterus, bicornuate uterus, didelphic uterus, septate uterus);adenomyosis;submucous uterine myoma, intrauterine adhesions and scarred uterus.

Design outcomes

Primary

Measure	Time frame
Clinical pregnancy rate;	—

Countries

China

Contacts

Public ContactShi Wenhao

Northwest Women and Children's Hospital

swihao@126.com+86 15771798519

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026